Jorge Gálvez

3.9k total citations
115 papers, 3.1k citations indexed

About

Jorge Gálvez is a scholar working on Computational Theory and Mathematics, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Jorge Gálvez has authored 115 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Computational Theory and Mathematics, 51 papers in Organic Chemistry and 30 papers in Molecular Biology. Recurrent topics in Jorge Gálvez's work include Computational Drug Discovery Methods (76 papers), Synthesis and biological activity (36 papers) and Analytical Chemistry and Chromatography (13 papers). Jorge Gálvez is often cited by papers focused on Computational Drug Discovery Methods (76 papers), Synthesis and biological activity (36 papers) and Analytical Chemistry and Chromatography (13 papers). Jorge Gálvez collaborates with scholars based in Spain, United States and France. Jorge Gálvez's co-authors include Ramón García‐Domenech, Jesus Vicente de Julián‐Ortiz, Rosa M. Soler, R. Garcia‐Domenech, Arkadiusz Z. Dudek, Tomasz Arodź, María Gálvez-Llompart, Ricardo Garcı́a, Lionello Pogliani and Francis Derouin and has published in prestigious journals such as Chemical Reviews, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jorge Gálvez

112 papers receiving 3.0k citations

Peers

Countries citing papers authored by Jorge Gálvez

Since Specialization

Citations

This map shows the geographic impact of Jorge Gálvez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Gálvez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Gálvez more than expected).

Fields of papers citing papers by Jorge Gálvez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Gálvez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Gálvez. The network helps show where Jorge Gálvez may publish in the future.

Co-authorship network of co-authors of Jorge Gálvez

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Gálvez. A scholar is included among the top collaborators of Jorge Gálvez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Gálvez. Jorge Gálvez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimizing trigger timing in minimal ovarian stimulation for In Vitro fertilization using machine learning models with random search hyperparameter tuning 2024 ·Computers in Biology and Medicine ·(unknown), (unknown), Omar Ávalos, Jorge Gálvez, (unknown), Liang Yu, Yimin Shu, Ming Feng, Frank D. Yelian	2
2	The role of donor type and pre‐transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia 2024 ·Pediatric Transplantation ·(unknown), Biljana Horn, (unknown), Michael Joyce, (unknown), (unknown), Kevin O. McNerney, (unknown), John Fort, (unknown), Jorge Gálvez, (unknown), John A. Ligon, (unknown), David Crawford, Deepak Chellapandian	0
3	Similarity-Based Virtual Screening to Find Antituberculosis Agents Based on Novel Scaffolds: Design, Syntheses and Pharmacological Assays 2022 ·International Journal of Molecular Sciences ·(unknown), Jesus Vicente de Julián‐Ortiz, Jorge Gálvez, David Font, (unknown), (unknown), (unknown), Rafael Borrás, José M. Villalgordo	2
4	Latest advances in molecular topology applications for drug discovery 2015 ·Expert Opinion on Drug Discovery ·(unknown), María Gálvez-Llompart, Ramón García‐Domenech, Jorge Gálvez	36
5	Advances in the molecular modeling and quantitative structure–activity relationship-based design for antihistamines 2013 ·Expert Opinion on Drug Discovery ·Jorge Gálvez, María Gálvez-Llompart, (unknown), Ramón García‐Domenech	7
6	Molecular topology as a novel approach for drug discovery 2012 ·Expert Opinion on Drug Discovery ·Jorge Gálvez, María Gálvez-Llompart, Ramón García‐Domenech	16
7	Búsqueda de modelos QSAR para la actividad repelente de sesquiterpenos naturales frente al mosquito de la Fiebre Amarilla, Aedes aegypti 2010 ·Afinidad ·Ramón García‐Domenech, (unknown), (unknown), (unknown), (unknown), Jorge Gálvez	3
8	MT103 inhibits tumor growth with minimal toxicity in murine model of lung carcinoma via induction of apoptosis 2010 ·Investigational New Drugs ·Piotr Jasiński, Pawel Zwolak, Rachel I. Vogel, Vidya Bodempudi, Kaoru Terai, Jorge Gálvez, (unknown), Arkadiusz Z. Dudek	12
9	Application of molecular topology to the prediction of mosquito repellents of a group of terpenoid compounds 2009 ·Molecular Diversity ·Ramón García‐Domenech, (unknown), (unknown), (unknown), Jorge Gálvez	17
10	A review on molecular topology: applying graph theory to drug discovery and design 2009 ·Die Naturwissenschaften ·José M. Amigó, Jorge Gálvez, Vincent M. Villar	35
11	Aplicación de la Topología Molecular en la búsqueda de nuevos agentes activos frente a Leishmania 2008 ·Anales de la Real Academia Nacional de Farmacia ·Ramón García‐Domenech, (unknown), (unknown), (unknown), (unknown), (unknown), Jorge Gálvez	1
12	Application of molecular topology to the prediction of the phenoloxidase inhibition by a group of benzaldehyde thiosemicarbazone and their derivatives 2008 ·Afinidad ·Ramón García‐Domenech, (unknown), (unknown), (unknown), (unknown), (unknown), Jorge Gálvez	0
13	Application of molecular topology to the prediction of the antimalarial activity of a group of uracil-based acyclic and deoxyuridine compounds 2008 ·International Journal of Pharmaceutics ·Ramón García‐Domenech, (unknown), (unknown), (unknown), (unknown), (unknown), Jorge Gálvez	13
14	Prediction of acute toxicity of organophosphorus pesticides using topological indices 2007 ·SAR and QSAR in environmental research ·Ramón García‐Domenech, Pedro María Alarcón‐Elbal, (unknown), Rubén Bueno‐Marí, (unknown), Sarah Delacour, (unknown), (unknown), Jorge Gálvez	15
15	A novel quinoline, MT477: suppresses cell signaling through Ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma cell lines 2007 ·Investigational New Drugs ·Piotr Jasiński, (unknown), Jorge Gálvez, (unknown), Pawel Zwolak, (unknown), Kaoru Terai, Arkadiusz Z. Dudek	41
16	Computational Methods in Developing Quantitative Structure-Activity Relationships (QSAR): A Review 2006 ·Combinatorial Chemistry & High Throughput Screening ·Arkadiusz Z. Dudek, Tomasz Arodź, Jorge Gálvez	304
17	Predictability and prediction of lowest observed adverse effect levels in a structurally heterogeneous set of chemicals 2005 ·SAR and QSAR in environmental research ·Jesus Vicente de Julián‐Ortiz, Ramón García‐Domenech, Jorge Gálvez, Lionello Pogliani	21
18	Optimization of a mathematical topological pattern for the prediction of antihistaminic activity 2001 ·Journal of Computer-Aided Molecular Design ·María J. Duart, Ramón García‐Domenech, G.M. Antón-Fos, Jorge Gálvez	21
19	New bronchodilators selected by molecular topology 1998 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), R. Garcia‐Domenech, Jorge Gálvez, Julio Cortijo, P Santamaría, Esteban Morcillo	48
20	Topological Approach to Drug Design 1995 ·Journal of Chemical Information and Computer Sciences ·Jorge Gálvez, R. Garcia‐Domenech, Jesus Vicente de Julián‐Ortiz, Rosa M. Soler	155

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact